|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/113 | (2006.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 2170403 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08763631.2 |
| Date of filing the European patent application | 2008-06-26 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-16 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (86) | Number | PCT/IL2008/000874 |
| Date | 2008-06-26 |
| (87) | Number | WO 2009/001359 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 937318 P | 2007-06-27 | US | |
| 964325 P | 2007-08-10 | US |
| (72) |
KALINSKI, Hagar, IL
METT, Igor, IL
FEINSTEIN, Elena, IL
ERLICH, Shai, Dr, US
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti proapoptotinių genų ekspresijos slopinimui |
| Compositions and methods for inhibiting expression of pro-apoptotic genes |
| Payment date | Validity (years) | Amount | |
| 2021-05-24 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-06-26 |